Home

Describing the Elephant in the Room
As I prepared to relaunch Tablets & Capsules with my CompareNetworks colleagues, I was reminded of the ancient Indian parable of the blind men and the elephant. Each touched a different part. The man who grabbed the tail called it a rope. The man who patted the trunk dubbed it a snake. And the man who tapped a leg labelled it a tree. read more
Packing It In: Communicating Standards and Guidelines with Suppliers Can Prevent Problems
Package quality disputes between suppliers and customers often start with someone in the filling plant stating “these packages aren’t as good as the ones we ran last week” without any data to support their suspicion. Data, not feelings, must be the basis of any package quality discussions with their supplier. read more
Preparing for the Unpredictable: Prescriptive Maintenance Can Improve Production by Tapping into Advanced Analytics
Predicting operational performance is a complex task in any industry. For pharmaceutical manufacturers, the ability to keep critical assets online and provide uninterrupted operations can mean the difference between life and death. read more
Raman Spectroscopy: Multiple Techniques Can Analyze Pharmaceutical Tablets and Capsules
Raman spectroscopy is emerging as a powerful analytical tool for the pharmaceutical industry. Like the more common FTIR spectroscopy, Raman spectroscopy is part of the vibrational spectroscopy family of analytic methods. Both methods provide a molecular fingerprint of the sample by probing the vibrations of the covalent bonds. read more

CHMP Recommends Approval of Lilly and Incyte's Alopecia Treatment
May 20, 2022
Eli Lilly and Company announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for OLUMIANT® (baricitinib) for the ... read more
Claudio Radossi Appointed President of MG America
May 20, 2022
MG America, the U.S. subsidiary of MG2 of Bologna, Italy and a leading supplier of processing and packaging equipment, has named Claudio Radossi as its next president, effective July 1. Radossi ... read more
Calliditas receives positive CHMP opinion in IgA nephropathy
May 19, 2022
Calliditas Therapeutics AB announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the granting of a ... read more
Gynecological Cancer Drugs Market Projected to Reach $21.8B by 2030
May 19, 2022
The global gynecological cancer drugs industry generated $11.6B in 2020, and is estimated to reach $21.8B by 2030, witnessing a CAGR of 6.5% from 2021 to 2030, according to a new report from Allied ... read more
Geriatric Population Driving GI Drug Growth
May 18, 2022
The global gastrointestinal drugs market is expected to grow from $71.85B in 2021 to $75.63B in 2022 at a compound annual growth rate (CAGR) of 5.3%. The change in growth trend is mainly due to the ... read more

Subscriptions

Get started here for your complimentary print or digital subscription
Sign up Now »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox!

Have a question about tooling, formulation, equipment, or processing?

Submit Your Question »

Featured Articles

Describing the Elephant in the Room

Packing It In: Communicating Standards and Guidelines with Suppliers Can Prevent Problems

Preparing for the Unpredictable: Prescriptive Maintenance Can Improve Production by Tapping into Advanced Analytics

Raman Spectroscopy: Multiple Techniques Can Analyze Pharmaceutical Tablets and Capsules

News

CHMP Recommends Approval of Lilly and Incyte's Alopecia Treatment

Claudio Radossi Appointed President of MG America

Calliditas receives positive CHMP opinion in IgA nephropathy

Gynecological Cancer Drugs Market Projected to Reach $21.8B by 2030

Geriatric Population Driving GI Drug Growth

Current Issue

March/April 2022

Subscriptions

Follow Us